Avoiding risks associated with injectable medicines using product labelling
  • product labelling

As a supplier of injectable medicines, hameln recognise the importance of getting things right first time

The risks associated with using injectable medicines in clinical areas have been recognised for some time. Traditionally, product packaging was viewed by the pharmaceutical industry as a marketing tool to show off corporate design and logos. At hameln, we have been increasingly aware of the importance of packaging as a medical device to aid healthcare workers identify the correct product accurately and efficiently, to minimise the risk of errors and enhance patient safety.

In the fields of intensive care medicine and anaesthesiology - the most frequently used applications for our injectable medicines - users must be able to select the right product correctly first time and every time. We are convinced that good packaging can significantly reduce the risk of incorrect administration of medication.

Our packaging is therefore created using design criteria that we have developed based on international legal requirements and in collaboration with clinical specialists, providing effective product identification and differentiation.


hameln labelling is constantly evolving using intelligent packaging design to help reduce the risk of medication errors

Our labelling was designed with input from hospital pharmacists, anaesthetists, other healthcare professionals, Medicines Authorities, the National Patient Safety Agency (UK) and trade associations from different countries. We continue to welcome customer/user feedback on how we can further improve our products.

The resulting packaging and labelling communicates essential information clearly and uses design elements such as symbols, stripes and colour to differentiate between products in our portfolio. The colour and marking schemes of each product are consistent between carton and ampoule label, to ensure that ampoules which have been already removed from their outer pack, for example in theatre, are also clearly identifiable.

Using different colours, stripes and symbols ensures that important details are highlighted


Where appropriate, the colour scheme recommended by the Intensive Care Society and Association of Anaesthetists1 has been adopted for the packaging and labelling.

Our focus is to listen to the ideas of our customers and turn them into solutions. GTIN barcodes are standard on all packs.

1 https://anaesthetists.org/Portals/0/PDFs/Guidelines%20PDFs/Guideline_syringe_labelling_critical_care_review_2014_updated_2016_final.pdf?ver=2018-07-11-163757-317&ver=2018-07-11-163757-317

We will continue to further improve our packaging design to help reduce
the incidence of medication errors.